Newly updated advice on using DMARDs for RA

INTRODUCTION Shared decision-making between patients and doctors is a central focus of newly updated recommendations on treating rheumatoid arthritis with disease-modifying antirheumatic drugs (DMARDs). The updated recommendations, produced by the European League Against Rheumatism (EULAR), also take into account recent research on the benefits and safety of these widely used drugs. WHAT DO WE KNOW ALREADY? When […]

Read More…

Rheumatoid arthritis: cheaper biological treatments on the horizon?

INTRODUCTION In recent years the so-called ‘biological’ treatments have marked a major step forward in the treatment of rheumatoid arthritis. Now a new study has looked at a similar treatment that may be cheaper and, therefore, available to more people. WHAT DO WE KNOW ALREADY? Research into rheumatoid arthritis has moved very quickly in the last 10 […]

Read More…

Do better treatments mean fewer appointments for rheumatoid arthritis?

INTRODUCTION Twenty-first-century treatments may be behind a drop in hospital and doctor visits for people with rheumatoid arthritis, according to a study in Sweden. WHAT DO WE KNOW ALREADY? In the first part of this century, a number of medicines have made a big difference to people living with the symptoms of rheumatoid arthritis, such as pain, […]

Read More…